FDA Approves Alternative Standard Breast Density Reporting
The Alternative Standard will allow the physician to provide an overall assessment of breast density with singular phrasing in reports of unilateral mammograms.
Read moreMain Content
MQSA Small Entity Compliance Guide
Aug. 23, 2024
The U.S. Food and Drug Administration (FDA) issued a Small Entity Compliance Guide (SECG) to assist small entities, including mammography facilities, in complying with the FDA’s March 2023 final rule amending regulations under the Mammography Quality Standards Act of 1992 (MQSA) and the Federal Food, Drug, and Cosmetic Act.
The amendments, which become effective September 10, 2024, will help modernize the regulations by incorporating current science and mammography best practices. Read the SECG
Related ACR News
Seven States Enact Breast Health Legislation
The 2025 state legislative sessions have seen an increased amount of breast health legislation and expanding access to screenings.
Read moreACR Commission Chair Participates in Congressional Panel
The event aimed to educate congressional staff and lawmakers about the need to ensure all women have access to the full continuum of breast imaging care.
Read more